Back to
Jefferies Financial Group Inc.
TGTX
Showing 2 of 4 quarters
Position history for
Jefferies Financial Group Inc.'s holdings in TG Therapeutics, Inc.
No. Jefferies Financial Group exited its TGTX (TG Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 16,000 shares worth $476,960. Jefferies Financial Group first reported TGTX in Q1 2023 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$476,960
Total Shares Change
-16,000
Quarter-by-Quarter History
Other major holders of TGTX: BlackRock, Inc., FMR LLC